119 related articles for article (PubMed ID: 8488716)
21. Nonspecific effects of oral vaccination with live-attenuated
Pennington SH; Ferreira DM; Caamaño-Gutiérrez E; Reiné J; Hewitt C; Hyder-Wright AD; Gordon SB; Gordon MA
Sci Adv; 2019 Feb; 5(2):eaau6849. PubMed ID: 30820452
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines.
Kantele A; Arvilommi H; Kantele JM; Rintala L; Mäkelä PH
Microb Pathog; 1991 Feb; 10(2):117-26. PubMed ID: 1890950
[TBL] [Abstract][Full Text] [Related]
23. A preliminary report on the immunological responses after oral vaccine (Ty 21a).
Sirianni MC; Turbessi G; Scarpati B; Russo G; Mascellino MT; Aiuti F
Boll Ist Sieroter Milan; 1984 Sep; 63(4):352-6. PubMed ID: 6394032
[TBL] [Abstract][Full Text] [Related]
24. Immunological study of typhoid: immunoglobulins, C3, antibodies, and leukocyte migration inhibition in patients with typhoid fever and TAB-vaccinated individuals.
Kumar R; Malaviya AN; Murthy RG; Venkataraman M; Mohapatra LN
Infect Immun; 1974 Dec; 10(6):1219-25. PubMed ID: 4215757
[TBL] [Abstract][Full Text] [Related]
25. A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children.
Tran TH; Nguyen TD; Nguyen TT; Ninh TT; Tran NB; Nguyen VM; Tran TT; Cao TT; Pham VM; Nguyen TC; Tran TD; Pham VT; To SD; Campbell JI; Stockwell E; Schultsz C; Simmons CP; Glover C; Lam W; Marques F; May JP; Upton A; Budhram R; Dougan G; Farrar J; Nguyen VV; Dolecek C
PLoS One; 2010 Jul; 5(7):e11778. PubMed ID: 20668668
[TBL] [Abstract][Full Text] [Related]
26. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.
Tagliabue A; Villa L; De Magistris MT; Romano M; Silvestri S; Boraschi D; Nencioni L
J Immunol; 1986 Sep; 137(5):1504-10. PubMed ID: 3489034
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
[TBL] [Abstract][Full Text] [Related]
28. Mucosal immunity to oral vaccines.
Ferguson A; Sallam J
Lancet; 1992 Jan; 339(8786):179. PubMed ID: 1346028
[No Abstract] [Full Text] [Related]
29. Assessment of the antibody response in 110 healthy individuals who have been subject to Vi capsular polysaccharide vaccine.
Dizer U; Görenek L; Güner O; Pehlivan T; Ozgüven V; Pahsa A
Vaccine; 2002 Aug; 20(25-26):3052-4. PubMed ID: 12163256
[TBL] [Abstract][Full Text] [Related]
30. The human humoral immune response to Salmonella typhi Ty21a.
Forrest BD; LaBrooy JT; Beyer L; Dearlove CE; Shearman DJ
J Infect Dis; 1991 Feb; 163(2):336-45. PubMed ID: 1988518
[TBL] [Abstract][Full Text] [Related]
31. Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine.
Forrest BD; LaBrooy JT; Robinson P; Dearlove CE; Shearman DJ
Infect Immun; 1991 Mar; 59(3):1206-9. PubMed ID: 1997425
[TBL] [Abstract][Full Text] [Related]
32. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
33. Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate.
Bellanti JA; Zeligs BJ; Vetro S; Pung YH; Luccioli S; Malavasic MJ; Hooke AM; Ubertini TR; Vanni R; Nencioni L
Vaccine; 1993; 11(5):587-90. PubMed ID: 8488717
[TBL] [Abstract][Full Text] [Related]
34. Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.
Keddy KH; Klugman KP; Hansford CF; Blondeau C; Bouveret le Cam NN
Vaccine; 1999 Jan; 17(2):110-3. PubMed ID: 9987143
[TBL] [Abstract][Full Text] [Related]
35. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
Wahid R; Fresnay S; Levine MM; Sztein MB
Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Lundgren A; Sack DA; Svennerholm AM; Qadri F
Vaccine; 2014 Feb; 32(9):1055-60. PubMed ID: 24440210
[TBL] [Abstract][Full Text] [Related]
37. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
[TBL] [Abstract][Full Text] [Related]
38. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
[TBL] [Abstract][Full Text] [Related]
39. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).
Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
Vaccine; 1999 Aug; 17(23-24):2941-5. PubMed ID: 10462227
[TBL] [Abstract][Full Text] [Related]
40. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
